STANDARDS OF GOOD PHARMACY PRACTICE AS A BASIS TO IMPLEMENT THE CONCEPT OF PHARMACEUTICAL CARE TO PATIENTS WITH DIABETES MELLITUS
DOI:
https://doi.org/10.11603/2312-0967.2022.1.13058Keywords:
diabetes mellitus, good pharmaceutical practice, pharmaceutical care, pharmacist, pharmacyAbstract
The aim of the work. To determine the attributes of Good Pharmacy Practice (GPP) in the implementation of the concept of pharmaceutical care for patients with diabetes which based on the analysis of international experience.
Materials and Methods. The objects of the study were information from the Internet databases PubMed, Cochrane Library and international guidelines. Content-analysis, bibliosemantic, logical, analytical, generalizing analyses were used.
Results and Discussion. Significant role of pharmacists in diabetic care was indicated by scientists. The implementation of GPP standards is effective in the process of providing pharmaceutical care. Pharmacists can improve diabetes outcomes by providing qualified pharmaceutical care. The introduction attributes of GPP is the world practice for providing pharmaceutical care to patients with diabetes. The attributes of the GPP in the implementation of the concept of pharmaceutical care for people with diabetes were established: informing about the risk factors of diabetes and promoting a healthy lifestyle; detection of undiagnosed and uncompensated diabetes; educating of patients of the selfmanagement in diabetes, etc.
Conclusion. In Ukraine, at this stage, the use of the achievements of the GPP standards, which focused on a specific chronic disease, such as diabetes, is almost not implemented in practice. The introduction of GPP should be preceded by a study of the needs of patients with diabetes and the relevance of introducing attributes of GPP for them in a pharmacy.
References
International diabetes federation Diabetes Atlas. 10th edition. URL: http://www. diabetesatlas.org.
Resolution WHO 24 May 2021 Reducing the burden of noncommunicable diseases through strengthening prevention and control of diabetes. URL: https://apps.who.int/gb/ebwha/pdf_files/WHA74/A74_ACONF5-en.pdf.
Benedict A, Spence M, Sie J. Evaluation of a pharmacist-managed diabetes program in a primary care setting within an integrated health care system. J Manag Care Spec Pharm. 2018;24(2): 114-22.
Zhyrova I. Methodical approaches to drug supply of patients with diabetes in terms of health insurance. Candidate’s thesis.: 15.00.01. NFU. Kh., 2004. Ukrainian.
Nemchenko A, Nazarkyna V. [Improving modern approaches to reference pricing for insulin drugs]. Farmats Zhurn. 2020;5: 23-33. Ukrainian.
Zaliska O, Huz V, Maksymovych N. Reimbursement Program "Affordable Medicines” in Ukraine: Issues and Challenges. Value in Health. 2020;23(2): 526.
Hermaniuk TA, Ivko TI, Bobruk VP. [Dynamics of availability of drugs for monotherapy of type 2 diabetes in Ukraine]. Farmats zhurn. 2017;1: 37-42. Ukrainian.
Hrem OIu. Optimization of pharmaceutical care for patients with type 2 diabetes mellitus (model of clinical pharmacist). Candidate’s thesis: 15.00.01. LNMU im. Danyla Halytskoho. Lviv; 2007. Ukrainian.
Boiko AI. [Analysis and management of factors that shape pharmaceutical care for patients with diabetes in Ukraine]. ScienceRise. 2016;3/4: 9-16. Ukrainian.
Vlasenko IO, Davtian LL. [Pharmaceutical supply of insulin preparations in Ukraine for 2016–2021]. Farmats chasopys. 2021;2: 55-64. Ukrainian.
Vlasenko IO. [Marketing study of the range of glucometers in the pharmaceutical market of Ukraine in 2021]. Farmats. zhurn. 2021;4: 32-42. Ukrainian.
Costa F, Scullin C, Al-Taani G. Provision of pharmaceutical care by community pharmacists across Europe: Is it developing and spreading? J Eval Clin Pract. 2017;23(6): 1336-47.
ASHP. Guidelines on Pharmacist-Conducted Patient Education and Counseling URL: https://www.ashp.org/-/media/assets/policy-guidelines/docs
Joint FIP/WHO Guidelines on Good Pharmacy Practice: Standards for Quality of Pharmacy Services. 2011. URL: http://apps.who.int/medicinedocs/en
FIP. Statement of professional standards Pharmaceutical care. The Hague, The Netherlands: FIP; 1998. URL: http://www.fip.org.
Hala LO. [Development of standards of good pharmacy practice in Ukraine to improve the quality of professional activity]. Farmats zhurn. 2014;5: 22-8. Ukrainian.
Kopciuch D, Paczkowska A, Zaprutko T. A survey of pharmacists' knowledge, attitudes and barriers in pharmaceutical care concept in Poland. BMC Med Educ. 2021;21(1): 458.
Vlasenko IO, Davtyan LL. Identification of barriers to providing pharmaceutical care for people with diabetes in Ukraine. Polish Journal of Science. 2020;27(1): 37-43.
Risøy A, Kjome R, Svensberg K. Pharmacists’ experience of a diabetes risk-assessment service and analytical quality control in community pharmacies – A focus-group study. Research in Social and Administrative Pharmacy. 2021;17: 1259-1266.
Elliott R, Tanajewski L, Gkountouras G. Cost effectiveness of support for people starting a new medication for a long-term condition through community pharmacies: an economic evaluation of the NMS compared with normal practice. Pharmacoeconomics. 2017;35: 1237-1255.
Stegbauer C, Falivena C, Moreno A. Costs and its drivers for diabetes mellitus type 2 patients in France and Germany: a systematic review of economic studies. BMC Health Serv Res. 2020;20(1): 1043.
Position Statement – The role of the pharmacist in providing care for people with type 2 diabetes – February 2009 Pharmaceutical Society of Australia.
Centers for Disease Control and Prevention. Rx for the National Diabetes Prevention Program: Action Guide for Community Pharmacists. Atlanta, US Dept of Health and Human Services; 2019.
Franch-Nadal J, Fornos J, Rodríguez de Miguel M. Management of prediabetes from the perspective of spanish physicians and community pharmacists. Detecta2 study. Value in Health. 2019;22(3): 588.
Fornos-Pérez J, Andrés-Rodríguez N, Andrés-Iglesias J, еt al. Detection of people at risk of diabetes in community pharmacies of Pontevedra (Spain). Endocrinología y Nutrición. 2016;63(8): 387-96.
Costa S, Horta M, Santos R. Diabetes policies and pharmacy-based diabetes interventions in Portugal: a comprehensive review Journal of Pharmaceutical Policy and Practice. 2019;12: 5.
Krass CL, Armour B. Mitchell. The Pharmacy Diabetes Care Program: assessment of a community pharmacy diabetes service model in Australia. Diabetic Medicine. 2007;24: 677-83.
Eikenhorst L, Taxis K, Dijk, Gier H. Pharmacist-led self-management interventions to improve diabetes outcomes. A systematic literature review and meta-analysis. Frontiers. Pharmacology. 2017;8: 891.
Machen M, Borden H, Hohmeier K. The impact of a community pharmacy diabetes self-management education program on diabetes distress. Journal of Pharmacy Technology. 2019;35(1): 3-10.
Chen J, Ou H, Lin T. Pharmaceutical care of elderly patients with poorly controlled type 2 diabetes mellitus: a randomized controlled trial. Int J Clin Pharm. 2016;38: 88-95.
Sarayani A, Mashayekhi M, Nosrati M. Efficacy of a telephone‑based intervention among patients with type‑2 diabetes; a randomized controlled trial in pharmacy practice. International Journal of Clinical Pharmacy. 2018;40: 345-53.
Sanyal C, Husereau D. Community-based services by pharmacists: A systematic review of cost-utility analyses. Value in Health. 2019;22(12): 1450-57.
Brewster S, Holt R, Portlock J, et al. The role of community pharmacists and their position in the delivery of diabetes care: an update for medical professionals. Postgrad Med J. 2020;96: 473-9.
Brown S, Al Hamarneh Y, Tsuyuki R. Economic analysis of insulin initiation by pharmacists in a Canadian setting: the xING study. Can Pharm J (Ott). 2016;149: 130-7.
Hasen G, Negeso B. Patients satisfaction with pharmaceutical care and associated factors in the Southwestern Ethiopia. Patient Prefer Adherence. 2021;15: 2155-63.
Katangwe T, Family H, Sokhi J. The community pharmacy setting for diabetes prevention: A mixed methods study in people with ‘pre-diabetes’. Research in Social and Administrative Pharmacy. 2020;16: 1067-80.
Blum L, Ekpenyong А. FIP. Diabetes prevention, screening, and management: A handbook for pharmacists. The Hague: FIP; 2021.
5th International Pharmaceutical Forum "PHARMACIES OF THE WORLD-2016". Pharmaceutical markets of the world and good pharmacy practice. URL: https://www.apteka.ua/article/375190. Ukrainian.
Kremin YI, Hromovyk BP. Research of the relationship between educational and professional programs of higher pharmaceutical education in Ukraine with the «Ten-star pharmacist» concept. Farmatsevtychnyi zhurnal. 2021;5: 27-36. https://doi.org/10.32352/0367-3057.5.21.03.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2022 Pharmaceutical Review / Farmacevtičnij časopis
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
The authors who publish their materials in this journal agree with the following terms:
- Authors reserve the right to authorship of their work and assign to the journal the right to first publish this work under the terms of the Creative Commons Attribution License, which allows other persons to freely distribute the published work with a mandatory reference to the authors of original work and the first publication of work in this journal
. - Authors have the right to make independent extra-exclusive work agreements in the form they are published by this journal (for example, posting work in an electronic repository of an institution or publishing as part of a monograph), provided that the link to the first publication of the work in this journal is maintained.
Journal policy allows and encourages publication of manuscripts on the Internet (for example, in institutions repositories or on personal websites), both before the publication of this manuscript and during its editorial review, as it contributes to productive scientific discussion and positively affects the efficiency and dynamics of the citation of the published work (see The Effect of Open Access).
